Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02903108Phase 3Completed
Phase 3, randomised, double-blind trial in chronic periodontitis comparing Boric acid group with Placebo group (2 arms). Primary endpoint: Radiographic Defect Depth Reduction at 6 months. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02903108.